Transient Ischemic Attack
📧 Sign up to get email alerts when something new happens for Transient Ischemic Attack.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-09-16FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Dr.Reddy's Laboratories Inc)
FDA approves a supplemental application for clopidogrel bisulfate from Dr. Reddy's Laboratories Inc, pertaining to the approved generic prod…
-
CLINICAL_TRIALS withdrawal · 2022-05-27Clinical Trial Update: The Middle East Dual Anti-platelet Treatment in Acute Transient Ischemic Attack [Phase 4]
A Phase 4 clinical trial evaluating dual antiplatelet therapy in acute transient ischemic attack and minor stroke has been withdrawn.
-
FDA approval · 2022-03-31FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (RADHA PHARMACEUTICALS, INC.)
FDA approved a supplemental application for clopidogrel bisulfate (Radha Pharmaceuticals, Inc.) under an ANDA, confirming its status as a ge…
-
CLINICAL_TRIALS trial_result · 2022-02-17Clinical Trial Update: Connected Health Blood Pressure Monitoring In Stroke and TIA Patients [NA]
A completed clinical trial evaluating connected health blood pressure monitoring in stroke and TIA patients; results posted in 2022.
-
FDA approval · 2021-12-21FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for clopidogrel bisulfate submitted by Dr. Reddy's Laboratories Limited. The action confirms approva…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-12-02Clinical Trial Update: Clopidogrel With Aspirin in High-risk Patients With Acute Non-disabling Cerebrovascular Events II [Phase 3]
Phase 3 trial update examining clopidogrel with aspirin in high-risk acute non-disabling cerebrovascular events has completed.
-
CLINICAL_TRIALS trial_result · 2021-11-30Clinical Trial Update: Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation [Phase 3]
Phase 3 trial update on apixaban for early prevention of recurrent embolic stroke and hemorrhagic transformation, completed with posted resu…
-
FDA approval · 2021-10-06FDA Approved: ASPIRIN AND DIPYRIDAMOLE — Supplemental Application (Dr. Reddy's Laboratories Inc)
The FDA approved a supplemental application for aspirin and dipyridamole from Dr. Reddy's Laboratories Inc, confirming regulatory clearance …
-
CLINICAL_TRIALS trial_result · 2021-09-20Clinical Trial Update: NUTRITION: Natural Tocotrienol Against Ischemic Stroke Event [Phase 1, Phase 2]
Clinical trial of Natural Tocotrienol for ischemic stroke and TIA completed (Phase 1/2).
-
FDA approval · 2021-08-11FDA Approved: ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE — Original Application (Micro Labs Limited)
FDA approved the original application for a generic aspirin and extended-release dipyridamole combination from Micro Labs Limited.
-
CLINICAL_TRIALS trial_result · 2021-06-11Clinical Trial Update: Comprehensive Post-Acute Stroke Services [NA]
Completed clinical trial evaluating post-acute stroke services; results posted in 2021.
-
FDA approval · 2021-04-14FDA Approved: ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE from Glenmark Pharmaceuticals Inc., USA, authorizing th…
-
CLINICAL_TRIALS trial_result · 2021-01-29Clinical Trial Update: Efficacy and Safety of Angong Niuhuang Wan for Stroke [Phase 2, Phase 3]
Clinical trial update for Angong Niuhuang Wan evaluating efficacy and safety in stroke and TIA patients across Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2021-01-28Clinical Trial Update: Revacept in Symptomatic Carotid Stenosis [Phase 2]
Phase 2 trial update for Revacept in symptomatic carotid stenosis; results completed and posted.
-
CLINICAL_TRIALS trial_result · 2020-12-22Clinical Trial Update: THALES - Acute STroke or Transient IscHaemic Attack Treated With TicAgreLor and ASA for PrEvention of Stroke and Death [Phase 3]
Phase 3 THALES trial evaluating ticagrelor plus aspirin for prevention of stroke and death after acute ischemic stroke or transient ischemic…
-
CLINICAL_TRIALS research · 2020-11-18Clinical Trial Update: Sleep Apnea in TIA/Stroke: Reducing Cardiovascular Risk With Positive Airway Pressure [NA]
Clinical trial update on using positive airway pressure to reduce cardiovascular risk in patients with sleep apnea and a history of transien…
-
CLINICAL_TRIALS trial_result · 2020-09-25Clinical Trial Update: VITATOPS: A Study of VITAmins TO Prevent Stroke [NA]
Clinical trial update for VITATOPS study; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2020-08-26Clinical Trial Update: Early Psychological Intervention to Prevent Cardiovascular Event-Induced PTSD (REACH Sub-study) [NA]
A terminated clinical trial investigating early psychological intervention to prevent PTSD after cardiovascular events; results posted in 20…
-
CLINICAL_TRIALS trial_result · 2020-07-24Clinical Trial Update: Platelet Reactivity in Acute Non-disabling Cerebrovascular Events [Phase 2, Phase 3]
Clinical trial update on platelet reactivity in acute non-disabling cerebrovascular events, spanning Phase 2 and Phase 3, completed.
-
CLINICAL_TRIALS trial_result · 2020-07-15Clinical Trial Update: Clopidogrel in High-risk Patients With Acute Non-disabling Cerebrovascular Events [Phase 3]
A Phase 3 trial evaluating clopidogrel in high-risk patients with acute non-disabling cerebrovascular events has completed.
-
CLINICAL_TRIALS trial_result · 2020-06-19Clinical Trial Update: Canadian Pradaxa Acute Stroke Safety Study
A completed Canadian safety study of Pradaxa (dabigatran) in acute stroke/Transient Ischemic Attack patients with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2019-12-19Clinical Trial Update: NBP in Patients With Moyamoya Disease of High Risk for Ischemic Cerebrovascular Events [Phase 3]
Phase 3 clinical trial update for NBP in Moyamoya disease patients at high risk of ischemic cerebrovascular events.
-
FDA approval · 2019-12-13FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (RADHA PHARMACEUTICALS, INC.)
FDA approved a supplemental application for Clopidogrel Bisulfate from Radha Pharmaceuticals, Inc., confirming approval of their generic pro…
-
CLINICAL_TRIALS trial_result · 2019-08-13Clinical Trial Update: Cardiac Rehabilitation for TIA Patients [Phase 3]
A Phase 3 clinical trial evaluating cardiac rehabilitation for patients with transient ischemic attack (TIA) has been completed.
-
FDA approval · 2019-08-02FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved Dr. Reddy's Laboratories' supplemental application for clopidogrel bisulfate, approving changes to the product's labeling.